Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Toya

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
International Journal of Hematology|October 25, 2024
Quizartinib with donor lymphocyte infusion for post-transplant relapse of FLT3-ITD-positive acute myeloid leukemiaFumihiko Ouchi, Naoki Shingai, Yuho Najima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 4, 2022
[Haploidentical hematopoietic stem cell transplantation for graft failure in myelodysplastic syndrome/myeloproliferative neoplasm-unclassifiable complicated with Stenotrophomonas maltophilia bacteremia]Junichi Mukae, Noritaka Sekiya, Chika Kato, et al.
International Journal of Hematology|October 15, 2021
Retrospective comparison of hematopoietic stem cell transplantation following reduced-intensity conditioning with fludarabine/low-dose melphalan plus 4 Gy TBI versus fludarabine/ busulfan plus 4 Gy TBIYuta Yamada, Shuntaro Ikegawa, Yuho Najima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 3, 2025
[Effectiveness and safety of ibrutinib for steroid-dependent/refractory chronic graft-versus-host disease: a single-center analysis]Fumihiko Ouchi, Yuho Najima, Kana Kato, et al.
Leukemia Research|June 1, 2021
Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center studyShunichiro Yasuda, Yuho Najima, Tatsuya Konishi, et al.
Hemasphere|July 14, 2025
PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and monosomy 7Hiroyoshi Kunimoto, Ayaka Miura, Maiko Sagisaka, et al.
Ejhaem|August 11, 2025
Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCTTakashi Toya, Yujiro Nakajima, Konan Hara, et al.
Cancer Medicine|August 28, 2023
Clinical outcomes in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma after second-line salvage chemotherapy: A retrospective studyYu Yagi, Yusuke Kanemasa, Yuki Sasaki, et al.
Scientific Reports|August 19, 2022
Impact of lung function impairment after allogeneic hematopoietic stem cell transplantationYuya Kishida, Naoki Shingai, Konan Hara, et al.
Vox Sanguinis|April 14, 2025
Drug-induced liver injury due to granulocyte colony-stimulating factor in a healthy donor for allogeneic peripheral blood stem cell transplantationKana Kato, Shuhei Kurosawa, Riki Yamakawa, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
International Journal of Hematology|October 25, 2024
Quizartinib with donor lymphocyte infusion for post-transplant relapse of FLT3-ITD-positive acute myeloid leukemiaFumihiko Ouchi, Naoki Shingai, Yuho Najima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 4, 2022
[Haploidentical hematopoietic stem cell transplantation for graft failure in myelodysplastic syndrome/myeloproliferative neoplasm-unclassifiable complicated with Stenotrophomonas maltophilia bacteremia]Junichi Mukae, Noritaka Sekiya, Chika Kato, et al.
International Journal of Hematology|October 15, 2021
Retrospective comparison of hematopoietic stem cell transplantation following reduced-intensity conditioning with fludarabine/low-dose melphalan plus 4 Gy TBI versus fludarabine/ busulfan plus 4 Gy TBIYuta Yamada, Shuntaro Ikegawa, Yuho Najima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 3, 2025
[Effectiveness and safety of ibrutinib for steroid-dependent/refractory chronic graft-versus-host disease: a single-center analysis]Fumihiko Ouchi, Yuho Najima, Kana Kato, et al.
Leukemia Research|June 1, 2021
Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center studyShunichiro Yasuda, Yuho Najima, Tatsuya Konishi, et al.
Hemasphere|July 14, 2025
PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and monosomy 7Hiroyoshi Kunimoto, Ayaka Miura, Maiko Sagisaka, et al.
Ejhaem|August 11, 2025
Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCTTakashi Toya, Yujiro Nakajima, Konan Hara, et al.
Cancer Medicine|August 28, 2023
Clinical outcomes in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma after second-line salvage chemotherapy: A retrospective studyYu Yagi, Yusuke Kanemasa, Yuki Sasaki, et al.
Scientific Reports|August 19, 2022
Impact of lung function impairment after allogeneic hematopoietic stem cell transplantationYuya Kishida, Naoki Shingai, Konan Hara, et al.
Vox Sanguinis|April 14, 2025
Drug-induced liver injury due to granulocyte colony-stimulating factor in a healthy donor for allogeneic peripheral blood stem cell transplantationKana Kato, Shuhei Kurosawa, Riki Yamakawa, et al.
Pageof 12